This is a good opportunity for long-term investors to pick quality small and midcap stocks at reasonable valuations.
With this, a total of 42 individuals and seven firms have so far been chargesheeted in the case which was initially registered by the Directorate of Revenue Intelligence, Gandhidham unit, Gujarat, on September 13, 2021.
The US president said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.
The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.
The total incentive outgo under the ambitious production-linked incentive (PLI) scheme is estimated to be less than Rs. 40,000 crore by the fiscal year 2024-25 (FY25), when it completes the fourth year of implementation, according to the government's internal estimates. This means only a fourth of the allocated Rs 1.97 trillion is expected to be utilised by the end of FY24, indicating that not all the 14 PLI schemes would have taken off fully. While three of the 14 schemes - large-scale electronics manufacturing, bulk drugs, and medical devices - were introduced in 2020, the remaining were launched the following year.
Refuting the opposition's claim that Manipur 'is burning', a senior government functionary said on Thursday that no killing has happened in the state since July 18 and asserted that peace and normalcy will be restored soon through ongoing talks with the two warring communities -- Meiteis and Kukis.
The Department of Pharmaceuticals has submitted a freight subsidy scheme for exporters to the Commerce Ministry so that they could take alternate routes and avoid transit through Europe, which is a shorter route with better connectivity.
Scarlette Keeling's mother, Fiona, had last week expressed fears of threats to her life from the drug cartel as according to her, she had exposed the drug trade in the state. Fiona, who had initiated the struggle against the police system and subsequently exposed the police's lethargy in the probe in Scarlette's death, had written a letter to the police seeking protection.
After the first quarter was washed out, exporters are now keeping their fingers crossed over a turnaround in outbound shipments to at least North America from September onwards. This comes even as other key destinations such as Europe may take longer to revive in FY24. Slowdown in key economies, as well as geopolitical tensions resulted in sluggish demand for Indian goods.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share deal.
Pharmaceutical companies in the country offering any financial incentive to doctors to prescribe particular drugs may become a thing of the past if the drug manufacturers decide to follow the strict code of conduct being implemented by a US industry trade group.
The Manipur government may hand over the recent case of illicit drug seizure, in which a Colonel-rank Defence Public Relations Officer and five others were arrested, to a central agency dealing with drug control, a senior minister has said.
The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. This indicates the price increase has been the major growth driver. Growth in the moving annual turnover (the previous 12 months' turnover) in December was 5.1 per cent and that in new product introduction 2.6 per cent, while volumes dipped 0.9 per cent, leading to an overall growth rate of 6.8 per cent, according to the data from market research firm Pharmatrac.
Sunovion Pharmaceuticals Inc is the owner of the Eszopiclone drug.
Wockhardt is recalling select drugs in the US, which were under import restrictions from the USFDA.
.jpg)
The move is expected to delay the introduction of low-priced medicines in the market.
When the artery going to the brain gets clogged or closes off, and a part of the brain goes without blood for too long, it is called an ischemic stroke.
The company's US-based subsidiary Lupin Pharmaceuticals Inc has launched its generic Rabeprazole Sodium delayed-release tablets, 20 mg in the American market after having received approval to market it from the US Food and Drug Administration, according to a statement by Lupin.
Negotiators from the two sides will meet in July either at Brussels or Geneva, additional secretary in the commerce ministry D K Mittal told PTI.
Indian pharmaceutical companies, which are increasingly choosing to settle patent litigation with global drug majors in the US, would have to be more cautious now.
Indian medicine accounted for over 50 per cent of all drug seizures in Europe for intellectual property rights violation last year. Industry experts said this indicates the seriousness of the problem. This data was revealed in the recently-released 2009 report of the European Union on the customs enforcement activities of its member states.
"We will crack down on the shack owners who play loud music beyond stipulated period of time, serve liquor till midnight and also encourage drugs in their premises," superintendent of police (North) Bosco George said.
Panjwar, 63 was involved in drug and weapons smuggling and was designated as a terrorist under the Unlawful Activities (Prevention) Act in July 2020.
Tamba was attacked by motorcycle-borne assailants at his residence in Sanant Nagar, a thickly populated area of old Lahore in the afternoon.
In an exclusive interview with PTI video, the minister also said an extensive risk-based analysis is done continuously to ensure the production of quality medicines in the country, and the government and regulators are always alert to ensure that no one dies due to spurious medicines.
Unlike India, the US is a free-pricing market.
Notwithstanding the fact that the country's pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders predict that the overall domestic pharma industry will only witness a price hike of 5-6 per cent. This is attributed to higher competitive intensity in the market. Krishnakumar V, executive director and chief operating officer (CEO) of Eris Lifesciences, a domestic-focused pharma company, noted that the NLEM segment experienced growth suppression of around 150 basis points due to price reductions during the January to July period this year.
If future episodes are as verbose and unwieldy, it might be difficult to keep from switching channels, points out Deepa Ghalot.
As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
The US spent $1.5 million a day since 2001 fighting the opium war in Afghanistan. After hundreds of airstrikes failed to curtail the Taliban's $200-million-a-year opium trade, the US military quietly ended the campaign when the Trump administration officials engaged in direct peace talks with the Taliban, notes Atanu Biswas.
"The credit turmoil that the world is seeing now is clearly the worst in history," says Habil Khorakiwala, executive chairman, Wockhardt. He should know, as his company finds itself in trouble over a Rs 3,400 crore debt burden.
Pharma firms will have to affix barcodes on consignments of all tertiary level packaging, such as cartons, following a government order.
Blockbusters, Oscar winners, fairy tales, indies and cute doggies, Sukanya Verma assures it's all there on OTT this week.
The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
The drug is licensed to Ranbaxy Laboratories from Cipher Pharmaceuticals Inc of Mississauga, Ontario. It is currently protected by two issued patents listed in the FDA's approved drug products list, which expire in September 2021, the company said in a statement.
The consignment was expected to fetch over Rs 300 crore if it had reached the market.
